Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524606 | NSE Symbol : | ISIN : INE415H01017 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
31-Jan-2025	08-Feb-2025	Quarterly Results	Quarterly Results OUTCOME OF BAORD MEETING (As Per BSE Announcement Dated on 08/02/2025)
05-Nov-2024	13-Nov-2024	Quarterly Results	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the unaudited financial results for the quarter/ half year ended 30.09.2024 OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on: 13/11/2024)
26-Aug-2024	03-Sep-2024	AGM	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2024 inter alia to consider and approve the Board report and other matters related to 31st Annual General Meeting of the Company. OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on: 03/09/2024)
31-Jul-2024	09-Aug-2024	Quarterly Results	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve NOTICE OF BOARD MEETING OUTCOME OF BOARD MEETING (As per BSE Announcement Dated on 09/08/2024)
22-May-2024	30-May-2024	Accounts	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve audited accounts along with the required annexures OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 30.05.2024)
12-Apr-2024	20-Apr-2024	Change in Auditors	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/04/2024 inter alia to consider and approve 1. To take note of general disclosures of interest of Directors under section 184 (1) in form MBP-1 for the year ended 2024-2025 2. To consider and approve the appointment of Abhay Bhandari & Associates Chartered Accountants as Internal Auditor of the Company for the Financial Year 2024-2025. 3. To consider and approve the appointment of Dipika Kataria Practicing Company Secretary as Secretarial Auditor of the Company for the year 2024-2025 4. Authority to Mr. Sudhir Sethi as signing authority to apply and sign all the tender related documents on behalf of the Company for the year 2024-2025 OUTCOME OF BOARD MEETING OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 20.04.2024)
01-Feb-2024	12-Feb-2024	Quarterly Results	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve the Unaudited Financial Result of the Company for the quarter ended 31st December2O23 OUTCOME OF BOARD MEETING UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER, 2023 (As Per BSE Announcement Dated on: 12/02/2024)
31-Oct-2023	08-Nov-2023	Quarterly Results	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve TO CONSIDER AND APPROVE THE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER 2023 OUTCOME OF BOARD MEETING UNAUDITED FINANCIAL RESULT FOR THE HALF YEAR ENDED 30TH SEPTEMBER, 2023 (As Per BSE Announcement Dated on 08/11/2023)
17-Aug-2023	25-Aug-2023	AGM	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2023 inter alia to consider and approve Board Meeting for consideration and approval of the Board report and other matters related to 30th Annual General Meeting of the Company OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 25/08/2023)
03-Aug-2023	12-Aug-2023	Quarterly Results	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve to consider and approve the Unaudited Financial Result of the Company for the quarter ended 30th June 2023. OUTCOME OF BOARD MEETING (As per BSE Announcement Dated on 12/08/2023)
18-May-2023	29-May-2023	Accounts	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve adopt the audited accounts for the year ended March 31 2023 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 OUTCOME OF BOARD MEETING (As Per BSE Announcement dated on 29.05.2023) Revised outcome (As Per BSE Announcement dated on 30.05.2023)
03-Feb-2023	13-Feb-2023	Quarterly Results	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve 1. the Unaudited Financial Result of the Company for the quarter ended 31st December2O22 2. the matter of increasing the Bank Guarantee (Non Fund Based) from 40 Lacs to 75 Lacs. OUTCOME OF BOARD MEETING UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER, 2023 (As Per BSE Announcement dated on 13.02.2023) UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER, 2022 Revised outcome (As Per BSE Announcement dated on 15.02.2023)
04-Nov-2022	14-Nov-2022	Quarterly Results	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve BOARD MEETING NOTICE OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 14.11.2022)
26-Aug-2022	02-Sep-2022	AGM	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2022 inter alia to consider and approve consideration and approval of the Board report and other matters related to 29th Annual General Meeting of the Company Outcome of the Board Meeting of the Company held on 2nd September, 2022 at the Corporate office of the Company u/r 30 of the SEBI (LODR) Regulations, 2015 for consideration and approval of the Board report and other matters related to 29th Annual General Meeting of the Company. (As Per BSE Announcement dated on 02.09.2022)
30-Jul-2022	09-Aug-2022	Quarterly Results	BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 inter alia to consider and approve the unaudited quarterly financial results for the quarter ended 30th June 2022 OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 09.08.2022)

1 2

LOGIN HERE

Beryl Drugs Ltd

Board Meeting